Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1997 Nov;35(11):2740–2744. doi: 10.1128/jcm.35.11.2740-2744.1997

Quantification of cytomegalovirus DNA in peripheral blood leukocytes by a branched-DNA signal amplification assay.

D N Chernoff 1, R C Miner 1, B S Hoo 1, L P Shen 1, R J Kelso 1, D Jekic-McMullen 1, J P Lalezari 1, S Chou 1, W L Drew 1, J A Kolberg 1
PMCID: PMC230052  PMID: 9350724

Abstract

Quantification of cytomegalovirus (CMV) DNA in blood may aid in the identification of patients at highest risk for developing CMV disease, the evaluation of new therapeutics, and the prompt recognition of drug-resistant CMV strains. A branched-DNA (bDNA) assay was developed for the reliable quantification of CMV DNA in peripheral blood leukocytes. The bDNA assay allowed for the highly specific and reproducible quantification of CMV DNA in clinical specimens. Furthermore, the bDNA assay was at least as sensitive as culture techniques and displayed a nearly 3 log10 dynamic range in quantification. Changes in CMV DNA levels measured by the bDNA assay in a human immunodeficiency virus-positive patient undergoing therapy were consistent with CMV culture, antigen, and genotype results and correlated with disease progression and resistance markers. The bDNA assay for the quantification of CMV DNA may provide a useful tool that can be used to aid physicians in monitoring disease progression, evaluating therapeutic regimens, and recognizing viral resistance and drug failure.

Full Text

The Full Text of this article is available as a PDF (208.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arribas J. R., Clifford D. B., Fichtenbaum C. J., Commins D. L., Powderly W. G., Storch G. A. Level of cytomegalovirus (CMV) DNA in cerebrospinal fluid of subjects with AIDS and CMV infection of the central nervous system. J Infect Dis. 1995 Aug;172(2):527–531. doi: 10.1093/infdis/172.2.527. [DOI] [PubMed] [Google Scholar]
  2. Biron K. K., Stanat S. C., Sorrell J. B., Fyfe J. A., Keller P. M., Lambe C. U., Nelson D. J. Metabolic activation of the nucleoside analog 9-[( 2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine in human diploid fibroblasts infected with human cytomegalovirus. Proc Natl Acad Sci U S A. 1985 Apr;82(8):2473–2477. doi: 10.1073/pnas.82.8.2473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bogner E., Reschke M., Reis B., Mockenhaupt T., Radsak K. Identification of the gene product encoded by ORF UL56 of the human cytomegalovirus genome. Virology. 1993 Sep;196(1):290–293. doi: 10.1006/viro.1993.1477. [DOI] [PubMed] [Google Scholar]
  4. Boivin G., Chou S., Quirk M. R., Erice A., Jordan M. C. Detection of ganciclovir resistance mutations quantitation of cytomegalovirus (CMV) DNA in leukocytes of patients with fatal disseminated CMV disease. J Infect Dis. 1996 Mar;173(3):523–528. doi: 10.1093/infdis/173.3.523. [DOI] [PubMed] [Google Scholar]
  5. Chou S. W., Dennison K. M. Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes. J Infect Dis. 1991 Jun;163(6):1229–1234. doi: 10.1093/infdis/163.6.1229. [DOI] [PubMed] [Google Scholar]
  6. Chou S., Guentzel S., Michels K. R., Miner R. C., Drew W. L. Frequency of UL97 phosphotransferase mutations related to ganciclovir resistance in clinical cytomegalovirus isolates. J Infect Dis. 1995 Jul;172(1):239–242. doi: 10.1093/infdis/172.1.239. [DOI] [PubMed] [Google Scholar]
  7. Collins M. L., Zayati C., Detmer J. J., Daly B., Kolberg J. A., Cha T. A., Irvine B. D., Tucker J., Urdea M. S. Preparation and characterization of RNA standards for use in quantitative branched DNA hybridization assays. Anal Biochem. 1995 Mar 20;226(1):120–129. doi: 10.1006/abio.1995.1199. [DOI] [PubMed] [Google Scholar]
  8. Davis G. L., Lau J. Y., Urdea M. S., Neuwald P. D., Wilber J. C., Lindsay K., Perrillo R. P., Albrecht J. Quantitative detection of hepatitis C virus RNA with a solid-phase signal amplification method: definition of optimal conditions for specimen collection and clinical application in interferon-treated patients. Hepatology. 1994 Jun;19(6):1337–1341. [PubMed] [Google Scholar]
  9. Detmer J., Lagier R., Flynn J., Zayati C., Kolberg J., Collins M., Urdea M., Sánchez-Pescador R. Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched-DNA technology. J Clin Microbiol. 1996 Apr;34(4):901–907. doi: 10.1128/jcm.34.4.901-907.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Dewar R. L., Highbarger H. C., Sarmiento M. D., Todd J. A., Vasudevachari M. B., Davey R. T., Jr, Kovacs J. A., Salzman N. P., Lane H. C., Urdea M. S. Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasma. J Infect Dis. 1994 Nov;170(5):1172–1179. doi: 10.1093/infdis/170.5.1172. [DOI] [PubMed] [Google Scholar]
  11. Drew W. L., Ives D., Lalezari J. P., Crumpacker C., Follansbee S. E., Spector S. A., Benson C. A., Friedberg D. N., Hubbard L., Stempien M. J. Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. Syntex Cooperative Oral Ganciclovir Study Group. N Engl J Med. 1995 Sep 7;333(10):615–620. doi: 10.1056/NEJM199509073331002. [DOI] [PubMed] [Google Scholar]
  12. Drew W. L., Miner R. C., Busch D. F., Follansbee S. E., Gullett J., Mehalko S. G., Gordon S. M., Owen W. F., Jr, Matthews T. R., Buhles W. C. Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infection. J Infect Dis. 1991 Apr;163(4):716–719. doi: 10.1093/infdis/163.4.716. [DOI] [PubMed] [Google Scholar]
  13. Drouet E., Colimon R., Michelson S., Fourcade N., Niveleau A., Ducerf C., Boibieux A., Chevallier M., Denoyel G. Monitoring levels of human cytomegalovirus DNA in blood after liver transplantation. J Clin Microbiol. 1995 Feb;33(2):389–394. doi: 10.1128/jcm.33.2.389-394.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Einsele H., Ehninger G., Hebart H., Wittkowski K. M., Schuler U., Jahn G., Mackes P., Herter M., Klingebiel T., Löffler J. Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation. Blood. 1995 Oct 1;86(7):2815–2820. [PubMed] [Google Scholar]
  15. Flood J., Drew W. L., Miner R., Jekic-McMullen D., Shen L. P., Kolberg J., Garvey J., Follansbee S., Poscher M. Diagnosis of cytomegalovirus (CMV) polyradiculopathy and documentation of in vivo anti-CMV activity in cerebrospinal fluid by using branched DNA signal amplification and antigen assays. J Infect Dis. 1997 Aug;176(2):348–352. doi: 10.1086/514051. [DOI] [PubMed] [Google Scholar]
  16. Gerna G., Furione M., Baldanti F., Sarasini A. Comparative quantitation of human cytomegalovirus DNA in blood leukocytes and plasma of transplant and AIDS patients. J Clin Microbiol. 1994 Nov;32(11):2709–2717. doi: 10.1128/jcm.32.11.2709-2717.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hendricks D. A., Stowe B. J., Hoo B. S., Kolberg J., Irvine B. D., Neuwald P. D., Urdea M. S., Perrillo R. P. Quantitation of HBV DNA in human serum using a branched DNA (bDNA) signal amplification assay. Am J Clin Pathol. 1995 Nov;104(5):537–546. doi: 10.1093/ajcp/104.5.537. [DOI] [PubMed] [Google Scholar]
  18. Hibberd P. L., Tolkoff-Rubin N. E., Conti D., Stuart F., Thistlethwaite J. R., Neylan J. F., Snydman D. R., Freeman R., Lorber M. I., Rubin R. H. Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients. A randomized controlled trial. Ann Intern Med. 1995 Jul 1;123(1):18–26. doi: 10.7326/0003-4819-123-1-199507010-00002. [DOI] [PubMed] [Google Scholar]
  19. Ho D. D., Neumann A. U., Perelson A. S., Chen W., Leonard J. M., Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature. 1995 Jan 12;373(6510):123–126. doi: 10.1038/373123a0. [DOI] [PubMed] [Google Scholar]
  20. Kühn J. E., Wendland T., Schäfer P., Möhring K., Wieland U., Elgas M., Eggers H. J. Monitoring of renal allograft recipients by quantitation of human cytomegalovirus genomes in peripheral blood leukocytes. J Med Virol. 1994 Dec;44(4):398–405. doi: 10.1002/jmv.1890440416. [DOI] [PubMed] [Google Scholar]
  21. Lalezari J. P., Drew W. L., Glutzer E., James C., Miner D., Flaherty J., Fisher P. E., Cundy K., Hannigan J., Martin J. C. (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine (cidofovir): results of a phase I/II study of a novel antiviral nucleotide analogue. J Infect Dis. 1995 Apr;171(4):788–796. doi: 10.1093/infdis/171.4.788. [DOI] [PubMed] [Google Scholar]
  22. Manez R., Kusne S., Rinaldo C., Aguado J. M., St George K., Grossi P., Frye B., Fung J. J., Ehrlich G. D. Time to detection of cytomegalovirus (CMV) DNA in blood leukocytes is a predictor for the development of CMV disease in CMV-seronegative recipients of allografts from CMV-seropositive donors following liver transplantation. J Infect Dis. 1996 May;173(5):1072–1076. doi: 10.1093/infdis/173.5.1072. [DOI] [PubMed] [Google Scholar]
  23. McCutchan J. A. Clinical impact of cytomegalovirus infections of the nervous system in patients with AIDS. Clin Infect Dis. 1995 Oct;21 (Suppl 2):S196–S201. doi: 10.1093/clinids/21.supplement_2.s196. [DOI] [PubMed] [Google Scholar]
  24. Mellors J. W., Rinaldo C. R., Jr, Gupta P., White R. M., Todd J. A., Kingsley L. A. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science. 1996 May 24;272(5265):1167–1170. doi: 10.1126/science.272.5265.1167. [DOI] [PubMed] [Google Scholar]
  25. Nolte F. S., Emmens R. K., Thurmond C., Mitchell P. S., Pascuzzi C., Devine S. M., Saral R., Wingard J. R. Early detection of human cytomegalovirus viremia in bone marrow transplant recipients by DNA amplification. J Clin Microbiol. 1995 May;33(5):1263–1266. doi: 10.1128/jcm.33.5.1263-1266.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Pachl C., Todd J. A., Kern D. G., Sheridan P. J., Fong S. J., Stempien M., Hoo B., Besemer D., Yeghiazarian T., Irvine B. Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA signal amplification assay. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Apr 15;8(5):446–454. doi: 10.1097/00042560-199504120-00003. [DOI] [PubMed] [Google Scholar]
  27. Polis M. A., Masur H. Promising new treatments for cytomegalovirus retinitis. JAMA. 1995 May 10;273(18):1457–1459. [PubMed] [Google Scholar]
  28. Pollard R. B. Cytomegalovirus infections in renal, heart, heart-lung and liver transplantation. Pediatr Infect Dis J. 1988 May;7(5 Suppl):S97–102. [PubMed] [Google Scholar]
  29. Rasmussen L., Morris S., Zipeto D., Fessel J., Wolitz R., Dowling A., Merigan T. C. Quantitation of human cytomegalovirus DNA from peripheral blood cells of human immunodeficiency virus-infected patients could predict cytomegalovirus retinitis. J Infect Dis. 1995 Jan;171(1):177–182. doi: 10.1093/infdis/171.1.177. [DOI] [PubMed] [Google Scholar]
  30. Schmidt C. A., Oettle H., Peng R., Neuhaus P., Blumhardt G., Lohmann R., Wilborn F., Osthoff K., Oertel J., Timm H. Comparison of polymerase chain reaction from plasma and buffy coat with antigen detection and occurrence of immunoglobulin M for the demonstration of cytomegalovirus infection after liver transplantation. Transplantation. 1995 Apr 27;59(8):1133–1138. [PubMed] [Google Scholar]
  31. Singh N., Yu V. L., Mieles L., Wagener M. M., Miner R. C., Gayowski T. High-dose acyclovir compared with short-course preemptive ganciclovir therapy to prevent cytomegalovirus disease in liver transplant recipients. A randomized trial. Ann Intern Med. 1994 Mar 1;120(5):375–381. doi: 10.7326/0003-4819-120-5-199403010-00004. [DOI] [PubMed] [Google Scholar]
  32. Spaete R. R., Thayer R. M., Probert W. S., Masiarz F. R., Chamberlain S. H., Rasmussen L., Merigan T. C., Pachl C. Human cytomegalovirus strain Towne glycoprotein B is processed by proteolytic cleavage. Virology. 1988 Nov;167(1):207–225. doi: 10.1016/0042-6822(88)90071-2. [DOI] [PubMed] [Google Scholar]
  33. Spector S. A., Hsia K., Wolf D., Shinkai M., Smith I. Molecular detection of human cytomegalovirus and determination of genotypic ganciclovir resistance in clinical specimens. Clin Infect Dis. 1995 Oct;21 (Suppl 2):S170–S173. doi: 10.1093/clinids/21.supplement_2.s170. [DOI] [PubMed] [Google Scholar]
  34. Spector S. A., McKinley G. F., Lalezari J. P., Samo T., Andruczk R., Follansbee S., Sparti P. D., Havlir D. V., Simpson G., Buhles W. Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. Roche Cooperative Oral Ganciclovir Study Group. N Engl J Med. 1996 Jun 6;334(23):1491–1497. doi: 10.1056/NEJM199606063342302. [DOI] [PubMed] [Google Scholar]
  35. The T. H., van den Berg A. P., Harmsen M. C., van der Bij W., van Son W. J. The cytomegalovirus antigenemia assay: a plea for standardization. Scand J Infect Dis Suppl. 1995;99:25–29. [PubMed] [Google Scholar]
  36. Weber B., Doerr H. W. Diagnosis and epidemiology of transfusion-associated human cytomegalovirus infection: recent developments. Infusionsther Transfusionsmed. 1994 Aug;21 (Suppl 1):32–39. doi: 10.1159/000223035. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES